PharmaTalkRadio

As viruses evolve to resist vaccines and therapeutics, new targeted approaches to deliver broad-spectrum antivirals are needed. In this podcast, Anil Diwan, President and Executive Chairman of NanoViricides Incorporated, explains some of the shortcomings of the current model of antiviral drug development and how NanoViricides developed a nanotechnology with a different approach to develop and deliver antiviral drugs. Anil also presents an overview of the scientific and clinical development of NanoViricides lead program, NV-387 as well as potential applications in different indications.  For more information about NanoViricides Incorporated, visit NanoViricides.com.  For more information about the annual  PODD drug delivery conference, please visit Drug-Delivery.org.

For more information, visit theconferenceforum.org

For more information, visit theconferenceforum.org

For more information, visit immuno-oncology360.org.

For more information, visit theconferenceforum.org.

For more information, visit theconferenceforum.org

To learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.

For more information, go to theconferenceforum.org

For more information, go to theconferenceforum.org

For more information, visit patientsaspartners.org.

For more information, go to IO360summit.com.

For more information, visit theconferenceforum.org.

Summary: The 2024 CRAACO: Clinical Research as a Care Option conference is a unique opportunity for pharma, healthcare and patients to come together and address how we can integrate healthcare and clinical research to improve patient access to clinical trials. In this short podcast, Valerie Bowling, Executive Director of the Conference Forum, outlines the key themes and sessions for the 9th annual meeting.

For more information, visit patientsaspartners.org.

For more information, visit theconferenceforum.org.